Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Utilize diversification as a key strategy for wealth preservation. Safeguard your investments against market fluctuations.
23,542 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
As AI and cloud demand shape the tech landscape in early 2026, investors debate whether broad exposure through XLK or...
Oil hovers near the $100 mark with talk of a path to $200. Retailers face margin pressure as households trim discreti...
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
Markets react to a high-stakes claim about Iran policy as four living ex-presidents deny involvement. Oil climbs, sto...
The YieldMax MSFT Option Income Strategy ETF (MSFO) continues to lure income-seeking investors with weekly payouts, b...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
Global markets tumbled as President Trump signaled a major escalation with Iran, sending oil higher and volatility so...
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
Palantir has sparked debate among investors with rapid growth and high expectations. This guide breaks down whether p...
For the first time in decades, Berkshire Hathaway held its annual meeting without Warren Buffett. Executives laid out...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...